{"doi":"10.1002/jev2.12067","title":"WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1","abstract":"<jats:title>Abstract</jats:title><jats:p>Both mesenchymal stem cells (MSCs) and their corresponding small extracellular vesicles (sEVs, commonly referred to as exosomes) share similar immunomodulatory properties that are potentially beneficial for the treatment of acute graft versus host disease (aGvHD). We report that clinical grade Wharton's Jelly‐derived MSCs (WJMSCs) secrete sEVs enriched in programmed death‐ligand 1 (PD‐L1), an essential ligand for an inhibitory immune checkpoint. A rapid increase in circulating sEV‐associated PD‐L1 was observed in patients with aGvHD and was directly associated with the infusion time of clinical grade WJMSCs. In addition, in vitro inhibitory antibody mediated blocking of sEV‐associated PD‐L1 restored T cell activation (TCA), suggesting a functional inhibitory role of sEVs‐PD‐L1. PD‐L1‐deficient sEVs isolated from WJMSCs following CRISPR‐Cas9 gene editing fail to inhibit TCA. Furthermore, we found that PD‐L1 is essential for WJMSC‐derived sEVs to modulate T cell receptors (TCRs). Our study reveals an important mechanism by which therapeutic WJMSCs modulate TCR‐mediated TCA through sEVs or sEV‐carried immune checkpoints. In addition, our clinical data suggest that sEV‐associated PD‐L1 may be not only useful in predicting the outcomes from WJMSC clinical administration, but also in developing cell‐independent therapy for aGvHD patients.</jats:p>","journal":"Journal of Extracellular Vesicles","year":2021,"id":611702,"datarank":0.6515708132780527,"base_score":4.343805421853684,"endowment":4.343805421853684,"self_citation_contribution":0.6515708132780527,"citation_network_contribution":0.0,"self_endowment_contribution":0.6515708132780527,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":76,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":4,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1574515,"name":"Rupal Soder","orcid":null,"position":1,"is_corresponding":false},{"id":1058505,"name":"Sunil Abhyankar","orcid":"0000-0002-8578-1226","position":2,"is_corresponding":false},{"id":436760,"name":"Haitham Abdelhakim","orcid":null,"position":3,"is_corresponding":false},{"id":1574516,"name":"Mitchell W. Braun","orcid":null,"position":4,"is_corresponding":false},{"id":1043275,"name":"Camille V. Trinidad","orcid":"0000-0003-3480-208X","position":5,"is_corresponding":false},{"id":1390900,"name":"Harsh B. Pathak","orcid":"0000-0002-7756-8580","position":6,"is_corresponding":false},{"id":1574517,"name":"Ziyan Pessetto","orcid":null,"position":7,"is_corresponding":false},{"id":888715,"name":"Clayton Deighan","orcid":null,"position":8,"is_corresponding":false},{"id":284136,"name":"Siddhartha Ganguly","orcid":"0000-0003-4920-762X","position":9,"is_corresponding":false},{"id":731250,"name":"Buddhadeb Dawn","orcid":"0000-0001-5890-115X","position":10,"is_corresponding":false},{"id":1574520,"name":"Joseph McGuirk","orcid":null,"position":11,"is_corresponding":false},{"id":435600,"name":"Neil Dunavin","orcid":"0000-0001-8892-0191","position":12,"is_corresponding":false},{"id":34241,"name":"Andrew K. Godwin","orcid":"0000-0002-3987-9580","position":13,"is_corresponding":false},{"id":436761,"name":"Meizhang Li","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1","abstract":"<jats:title>Abstract</jats:title><jats:p>Both mesenchymal stem cells (MSCs) and their corresponding small extracellular vesicles (sEVs, commonly referred to as exosomes) share similar immunomodulatory properties that are potentially beneficial for the treatment of acute graft versus host disease (aGvHD). We report that clinical grade Wharton's Jelly‐derived MSCs (WJMSCs) secrete sEVs enriched in programmed death‐ligand 1 (PD‐L1), an essential ligand for an inhibitory immune checkpoint. A rapid increase in circulating sEV‐associated PD‐L1 was observed in patients with aGvHD and was directly associated with the infusion time of clinical grade WJMSCs. In addition, in vitro inhibitory antibody mediated blocking of sEV‐associated PD‐L1 restored T cell activation (TCA), suggesting a functional inhibitory role of sEVs‐PD‐L1. PD‐L1‐deficient sEVs isolated from WJMSCs following CRISPR‐Cas9 gene editing fail to inhibit TCA. Furthermore, we found that PD‐L1 is essential for WJMSC‐derived sEVs to modulate T cell receptors (TCRs). Our study reveals an important mechanism by which therapeutic WJMSCs modulate TCR‐mediated TCA through sEVs or sEV‐carried immune checkpoints. In addition, our clinical data suggest that sEV‐associated PD‐L1 may be not only useful in predicting the outcomes from WJMSC clinical administration, but also in developing cell‐independent therapy for aGvHD patients.</jats:p>","is_dataset_classified":null,"base_score":4.343805421853684,"endowment":4.343805421853684,"datacite_reuse_total":4,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33598108","pmcid":"PMC7869022","openalex_id":"https://openalex.org/W3128005349","authors":[],"funders":[{"funder_name":"National Institute of General Medical Sciences","grant_id":"P20 GM130423","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"P20 GM104936","title":null},{"funder_name":"NCRR NIH HHS","grant_id":"S10 RR027564","title":null},{"funder_name":"NCI NIH HHS","grant_id":"P30 CA168524","title":null},{"funder_name":"National Institutes of Health","grant_id":"3P30CA168524-07S2","title":"Cancer Center Support Grant"},{"funder_name":"National Institutes of Health","grant_id":"4P20GM104936-10","title":"Molecular Regulation of Cell Development and Differentiation"},{"funder_name":"National Institutes of Health","grant_id":"1S10RR027564-01","title":"JEOL JEM-1400 Transmission Electron Microscope with AMT-XR611M Digital Camera Sys"},{"funder_name":"National Institutes of Health","grant_id":"5P20GM130423-03","title":"The Kansas Institute for Precision Medicine"}],"total_grants":8,"fwci":3.8505,"citation_percentile":0.95075488,"influential_citations":0,"citation_trend":[{"year":2021,"count":8},{"year":2022,"count":13},{"year":2023,"count":16},{"year":2024,"count":15},{"year":2025,"count":16},{"year":2026,"count":8}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12067","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12067","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/jev2.12067","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jev2.12067","host_type":"publisher"},{"url":"https://isevjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/jev2.12067","host_type":"publisher"},{"url":"https://doi.org/10.1002/jev2.12067","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33598108","host_type":"repository"},{"url":"https://digitalscholarship.unlv.edu/som_fac_articles/609","host_type":"repository"},{"url":"https://doaj.org/article/21f1166dd8c24d04b0b82445de312aa4","host_type":"repository"},{"url":"https://oasis.library.unlv.edu/som_fac_articles/609","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7869022","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC7869022","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC7869022?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1002/jev2.12067","host_type":""},{"url":"https://dx.doi.org/10.1002/jev2.12067","host_type":""},{"url":"https://doi.org/https://doi.org/10.1002/jev2.12067","host_type":""}],"fields_of_study":["Extracellular vesicles in disease","Phagocytosis and Immune Regulation","Immune cells in cancer","0301 basic medicine","03 medical and health sciences","Adolescent","Adult","B7-H1 Antigen","Cells, Cultured","Cytokines","Exosomes","Extracellular Vesicles","Female","Gene Knockout Techniques","Graft vs Host Disease","Humans","Lymphocyte Activation","Mesenchymal Stem Cells","Pregnancy","Receptors, Antigen, T-Cell","T-Lymphocytes","Wharton Jelly","Young Adult"],"mesh_terms":["Extracellular Vesicles","Adolescent","Adult","Cells, Cultured","Female","Graft vs Host Disease","Humans","Lymphocyte Activation","Pregnancy","Receptors, Antigen, T-Cell","T-Lymphocytes","Cytokines","Exosomes","Gene Knockout Techniques","Young Adult","Mesenchymal Stem Cells","Wharton Jelly","B7-H1 Antigen"],"keywords":["Extracellular vesicles","Extracellular vesicle","Extracellular","Cell biology","Vesicle","Chemistry","Microvesicles","Biophysics","Biology","Biochemistry","Membrane","Gene","microRNA","T cell receptor","Small Extracellular Vesicles","Wharton'S Jelly‐Derived Mesenchymal Stem Cells","Pd‐l1","Acute Graft‐versus‐host Disease","PD-L1","Adult","Adolescent","T-Lymphocytes","Wharton's jelly-derived mesenchymal stem cells","Receptors, Antigen, T-Cell","Graft vs Host Disease","Exosomes","Lymphocyte Activation","B7-H1 Antigen","Gene Knockout Techniques","Young Adult","Pregnancy","and Immunity","Humans","Wharton Jelly","Research Articles","Cells, Cultured","Biological Phenomena","Acute graft-versus-host disease","QH573-671","Cell Phenomena","Mesenchymal Stem Cells","Cytokines","Female","Cytology"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.26578214.v1","title":"Additional file 1 of Exosome inspired photo-triggered gelation hydrogel composite on modulating immune pathogenesis for treating rheumatoid arthritis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26578214","title":"Additional file 1 of Exosome inspired photo-triggered gelation hydrogel composite on modulating immune pathogenesis for treating rheumatoid arthritis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.15102615","title":"Additional file 1 of Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.15102615.v1","title":"Additional file 1 of Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine","publisher":"figshare","resource_type":"Image"}],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-01T21:54:57.639597Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}